| Identification | Back Directory | [Name]
1H-Imidazo[4,5-b]pyridine, 1-[[5-[(1R)-1-fluoroethyl]-1,3,4-oxadiazol-2-yl]methyl]-6-(4-methoxypyrrolo[2,1-f][1,2,4]triazin-5-yl)-2-methyl- | [CAS]
2144751-78-8 | [Synonyms]
CTX-712
1H-Imidazo[4,5-b]pyridine, 1-[[5-[(1R)-1-fluoroethyl]-1,3,4-oxadiazol-2-yl]methyl]-6-(4-methoxypyrrolo[2,1-f][1,2,4]triazin-5-yl)-2-methyl- | [Molecular Formula]
C19H17FN8O2 | [MOL File]
2144751-78-8.mol | [Molecular Weight]
408.39 |
| Hazard Information | Back Directory | [Biological Activity]
CTX-712 is a potent inhibitor of cdc2-like kinase (CLK). CTX-712 inhibits CLK kinase activity, and thus inhibits cancer survival and cancer cell growth. CTX-712 has the potential for the research of cancer disease (extracted from patent JPWO2017188374A1, compound 286)[1]. | [storage]
Store at -20°C | [References]
[1]. Fused heterocyclic compounds. Patent JPWO2017188374A1. |
|
|